SCHEMBL6384852

SCHEMBL6384852

O=C(Nc1ccc(Oc2ccnc(C3=NCCN3)c2)cc1)N(c1ccc(Cl)c(C(F)(F)F)c1)N(C(=O)Nc1ccc(Oc2ccnc(-c3nnco3)c2)cc1)c1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 7/20 0.47
KDR P35968 10/20 0.46
FLT1 P17948 2/20 0.46
BRAF P15056 2/20 0.45
HDAC3 O15379 4/20 0.43
HDAC4 P56524 4/20 0.43
HDAC1 Q13547 4/20 0.43
HDAC7 Q8WUI4 4/20 0.43
HDAC2 Q92769 4/20 0.43
HDAC10 Q969S8 4/20 0.43
HDAC11 Q96DB2 4/20 0.43
HDAC8 Q9BY41 4/20 0.43
HDAC6 Q9UBN7 4/20 0.43
HDAC9 Q9UKV0 4/20 0.43
HDAC5 Q9UQL6 4/20 0.43
PDGFRB P09619 2/20 0.42
MEN1 O00255 1/20 0.42
PLK4 O00444 1/20 0.42
CIT O14578 1/20 0.42
AURKA O14965 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6384853 0.91 RAF1 (0.58) RAF1KDRFLT1BRAFHDAC3
SCHEMBL5446241 0.85 RAF1 (0.54) RAF1KDRFLT1BRAFHDAC3
SCHEMBL6388341 0.85 RAF1 (0.51) RAF1KDRFLT1BRAFHDAC3
SCHEMBL5437656 0.82 RAF1 (0.58) RAF1KDRFLT1BRAFHDAC3
SCHEMBL3406605 0.81 RAF1 (0.65) RAF1KDRFLT1BRAFHDAC3
SCHEMBL3413370 0.81 RAF1 (0.68) RAF1KDRFLT1BRAFHDAC3
SCHEMBL5447334 0.79 RET (0.49) RAF1KDRFLT1BRAFPDGFRB
SCHEMBL14447685 0.77 RAF1 (0.50) RAF1KDRFLT1BRAFPDGFRB
SCHEMBL3543215 0.76 RAF1 (0.67) RAF1KDRFLT1BRAFHDAC3
SCHEMBL5337325 0.75 RET (0.63) RAF1KDRFLT1BRAFPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603879-A2 SUBSTITUTED PYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS Bayer Pharmaceuticals Corporation (US) 2005-12-14 EP claimed
WO-2004078128-A2 SUBSTITUTED PYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-09-16 WO claimed